BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27752903)

  • 21. Diagnostic and prognostic value of procalcitonin and C-reactive protein in malnourished children.
    Page AL; de Rekeneire N; Sayadi S; Aberrane S; Janssens AC; Dehoux M; Baron E
    Pediatrics; 2014 Feb; 133(2):e363-70. PubMed ID: 24446443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Assay for determination of the serum procalcitonin level: biochemical and clinical evaluation].
    Shimetani N; Ohba Y; Shimetani K; Mashiko T; Matsuyama N; Ohtani H; Morii M
    Rinsho Byori; 2001 Jan; 49(1):56-60. PubMed ID: 11215485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein +1444CT (rs1130864) genetic polymorphism is associated with the susceptibility to systemic lupus erythematosus and C-reactive protein levels.
    Delongui F; Lozovoy MAB; Iriyoda TMV; Costa NT; Stadtlober NP; Alfieri DF; Flauzino T; Dichi I; Simão ANC; Reiche EMV
    Clin Rheumatol; 2017 Aug; 36(8):1779-1788. PubMed ID: 28567557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of MBL, PCT, CRP, neutrophil-lymphocyte ratio, and platelet lymphocyte ratio in differentiating infections from flares in lupus.
    Musunuri B; Tripathy R; Padhi S; Panda AK; Das BK
    Clin Rheumatol; 2022 Nov; 41(11):3337-3344. PubMed ID: 35835900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies to C-reactive protein in incomplete lupus and systemic lupus erythematosus.
    Jung JY; Koh BR; Kim HA; Jeon JY; Suh CH
    J Investig Med; 2014 Aug; 62(6):890-3. PubMed ID: 24896736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients.
    Cheval C; Timsit JF; Garrouste-Orgeas M; Assicot M; De Jonghe B; Misset B; Bohuon C; Carlet J
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S153-8. PubMed ID: 18470711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procalcitonin serum levels in perinatal bacterial and fungal infection of preterm infants.
    Distefano G; Curreri R; Betta P; Romeo MG; Amato M
    Acta Paediatr; 2004 Feb; 93(2):216-9. PubMed ID: 15046277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children.
    Agnello L; Bellia C; Di Gangi M; Lo Sasso B; Calvaruso L; Bivona G; Scazzone C; Dones P; Ciaccio M
    Clin Biochem; 2016 Jan; 49(1-2):47-50. PubMed ID: 26386341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus.
    Sjöwall C; Bengtsson AA; Sturfelt G; Skogh T
    Arthritis Res Ther; 2004; 6(2):R87-94. PubMed ID: 15059271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Matrix metalloproteinase-3 in patients with systemic lupus erythematosus and its significance in differentiating disease activity from pulmonary infections].
    Li MY; Bai YQ; Liu Y
    Zhonghua Nei Ke Za Zhi; 2020 Jan; 59(1):58-61. PubMed ID: 31887838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of Prediction Models for New Integrated Models and a Bioscore System to Identify Bacterial Infections in Systemic Lupus Erythematosus.
    Zhai X; Feng M; Guo H; Liang Z; Wang Y; Qin Y; Wu Y; Zhao X; Gao C; Luo J
    Front Cell Infect Microbiol; 2021; 11():620372. PubMed ID: 33732661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk.
    Barnes EV; Narain S; Naranjo A; Shuster J; Segal MS; Sobel ES; Armstrong AE; Santiago BE; Reeves WH; Richards HB
    Lupus; 2005; 14(8):576-82. PubMed ID: 16175928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.
    Papp M; Tornai T; Vitalis Z; Tornai I; Tornai D; Dinya T; Sumegi A; Antal-Szalmas P
    World J Gastroenterol; 2016 Nov; 22(41):9172-9185. PubMed ID: 27895404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of the measurement of serum procalcitonin: comparative study of procalcitonin and serum amyloid A protein in patients with high and low concentrations of serum C-reactive protein.
    Shimetani N; Shimetani K; Mori M
    Scand J Clin Lab Invest; 2004; 64(5):469-74. PubMed ID: 15276911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is initial C-reactive protein level associated with corticosteroid use in lupus erythematosus patients during a bacterial infection episode?
    Wang KC; Liu PH; Yu KH; Weng YM; Ng CJ; Chiu TF; Chen SY
    Immunol Lett; 2017 May; 185():84-89. PubMed ID: 28286229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of serum procalcitonin in establishing the diagnosis and prognosis of pleural infection.
    Dixon G; Lama-Lopez A; Bintcliffe OJ; Morley AJ; Hooper CE; Maskell NA
    Respir Res; 2017 Feb; 18(1):30. PubMed ID: 28158976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of C-reactive protein in systemic lupus erythematosus].
    Cengić M; Heljić B; Rasić S; Dilić M
    Med Arh; 2002; 56(3):147-9. PubMed ID: 12378859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracies of procalcitonin and C-reactive protein for bacterial infection in patients with systemic rheumatic diseases: a meta-analysis.
    Song GG; Bae SC; Lee YH
    Clin Exp Rheumatol; 2015; 33(2):166-73. PubMed ID: 25602442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.
    Xiao Y; Luo H; Zhou B; Dai X; Huang J; Duan L; You Y; Zhang W; Zhao H; Xie Y; Zhou Y; Ning W; Li T; Liu S; Zhu H; Xie X; Jiang Y; Wu S; He W; Li Y
    Rheumatol Int; 2017 Apr; 37(4):585-592. PubMed ID: 27878344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.